Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology

J. L. Fleiss, J. T. Bigger, M. McDermott, J. P. Miller, T. Moon, A. J. Moss, D. Oakes, L. M. Rolnitzky, T. M. Therneau

Research output: Contribution to journalEditorial

22 Scopus citations
Original languageEnglish
Pages (from-to)684-685
Number of pages2
Issue number2
StatePublished - 1990

Cite this